Medical Journals

Potent Analgesic Effects of a Putative Sodium Channel Blocker M58373 on Formalin-induced and Neuropathic Pain in Rats.

Authors:
  • Akada Yasushige
  • Ogawa Shinichi
  • Amano Ken-ichi
  • Fukudome Yuka
  • Yamasaki Fumiaki
  • Itoh Manabu
  • Yamamoto Ichiro

From: Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., 722 Jimba-aza-Uenohara, Gotemba, Shizuoka 412-8524, Japan. yakada@mochida.co.jp

European journal of pharmacology

  • Publish Date: May 2006
  • ISSN: 0014-2999
  • Volume: 536
  • Issue: 3
  • Pages: 248-55
  • Medium: Print
  • Language: English
  • Citation (JAMA): Akada Yasushige, Ogawa Shinichi, Amano Ken-ichi, et al. Potent Analgesic Effects of a Putative Sodium Channel Blocker M58373 on Formalin-induced and Neuropathic Pain in Rats.. Eur. J. Pharmacol. May 2006;536:248-55

Abstract

M58373, 4-[2-(4-hydroxy-4-{[N-(4-isopropoxyphenyl)-N-methylamino]methyl}piperidin-1-yl)ethyl]benzonitrile monohydrochloride, is a novel compound, which has an inhibitory activity on neurotoxin binding to the site 2 of voltage-gated sodium channels. In this study, we investigated the effects of M58373 on substance P release from sensory neurons in vitro and pain behaviors/responses in rats, compared with mexiletine. M58373 (1-10 microM) inhibited veratridine-induced release of substance P from dorsal root ganglion cells. In the formalin test, oral M58373 (0.3-10 mg/kg) reduced the time spent in nociceptive behaviors only in the late phase. In the neuropathic pain model, oral M58373 (1-10 mg/kg) attenuated mechanical allodynia and heat hyperalgesia in the nerve-injured paw without affecting normal responses in the uninjured paw. In contrast, oral mexiletine (10-100 mg/kg) had a narrow therapeutic dose range in both models because of the adverse effects on the central nervous system. These results suggest that M58373 is a favorable prototype for novel anti-neuropathic pain agents.

Mesh Headings (Keywords): Analgesics, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Formaldehyde, Ganglia, Spinal, Heat, Hyperalgesia, Male, Mexiletine, Motor Activity, Neuralgia, Nitriles, Pain, Pain Measurement, Piperidines, Rats, Rats, Wistar, Sodium Channel Blockers, Stress, Mechanical, Substance P, Veratridine


Check for Full Text / PubMed Unique Identifier (PMID): 16603152


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.